20 November, Crown Promenade (and online via Zoom)

Following on from the ACTA Symposium, join us for this one-day meeting exploring modern approaches to clinical trial design, development and analysis.
Early bird registration is available until September 26. See the website for ticket pricing and inclusions.

The program will commence with a Career Development Breakfast, providing opportunities for networking and professional growth. This will be followed by the Opening Plenary: Guidelines and Developments in Adaptive Trials and Rare Diseases. Participants will then be invited to attend The Debate: Have contemporary approaches to rare disease trials gone too far? The afternoon continues with contributed presentations, followed by the session Endpoints That Matter, which will explore the selection, development, and analysis of meaningful trial endpoints.

Invited Speakers

Thomas Jaki (University of Cambridge, UK) | Kert Viele (Berry Consultants, US)

James Matcham (Cytel, US/Aus) | Kate Lee (Murdoch Children’s Research Institute)

Thomas Snelling (University of Sydney) | Ian Marschner (NHMRC CTC)

Liz Ryan (Monash University) | Julie Marsh (The Kids’ Institute, WA)

Steve Webb (Monash University) | Kristy Robledo (University of Sydney)

Hannah Johns (University of Melbourne) | Charlie McLeod (The Kids’ Institute, WA)

Chris Selman (Murdoch Children’s Research Institute) | Melinda Cruz (NHMRC CTC)

More information can be found on the conference website.